BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 18-May-2015

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 19.05.2015 to 20.05.2015. Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2015.

ORIONPHARM 17-May-2015

(Q1 Un-audited): Consolidated Net Profit after tax (excluding non controlling interest) from Jan'15 to March'15 was Tk. 330.26 million with consolidated EPS of Tk. 1.41 as against Tk. 380.80 million and Tk. 1.63 respectively for the same period of the previous year.

ORIONPHARM 13-May-2015

There will be no price limit on the trading of the shares of the Company today (13.05.2015) following its corporate declaration.

ORIONPHARM 13-May-2015

The Board of Directors has recommended 15% cash dividend for the year ended on December 31, 2014. Date of AGM: 28.06.2015, Time: 10:30 AM, Venue: Orion Pharma Plant, Shumilpara, Siddirgonj (South Adjacent of Adamjee EPZ), Narayongonj. Record Date: 21.05.2015. The Company has also reported consolidated EPS of Tk. 4.25, consolidated NAV per share of Tk. 67.50 and consolidated NOCFPS of Tk. 13.98 for the year ended on December 31, 2014.

ORIONPHARM 06-May-2015

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 12, 2015 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2014.

ORIONPHARM 11-Jan-2015

Credit Rating Agency of Bangladesh Limited (CRAB) has announced the entity rating (surveillance) of the Company as "A1" with a stable outlook based on audited financial statement up to December 31, 2013, bank liability position as of November 30, 2014 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

ORIONPHARM 30-Oct-2014

(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported consolidated net profit after tax (excluding non-controlling interests) of Tk. 179.34 million with consolidated EPS of Tk. 0.77 as against Tk. 229.86 million and Tk. 0.98 respectively for the same period of the previous year. Whereas consolidated net profit after tax (excluding non-controlling interests) was Tk. 888.98 million with consolidated EPS of Tk. 3.80 for the period of nine months (Jan'14 to Sep'14) ended on 30.09.2014 as against Tk. 772.17 million and Tk. 3.30 respectively for the same period of the previous year.

ORIONPHARM 21-May-2014

Normal trading of the shares of the Company will resume on 22.05.2014 after record date.

ORIONPHARM 20-May-2014

Trading of the shares of the Company will remain suspended on record date i.e., 21.05.2014.

ORIONPHARM 15-May-2014

(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Company has reported consolidated net profit after tax (excluding non-controlling interest) of Tk. 380.79 million with consolidated EPS of Tk. 1.63 as against Tk. 294.17 million and Tk. 1.26 respectively for the same period of the previous year.

Previous Next page